PreCheck Health Services Inc. (fka HLTY)

[TheStellarTrader]

Adding , this is a monster 8$ pt

[eageleye]

How is this under the radar on this board? Not many posters considering the news.

[UP Trend]

2 million float, explains the big move.

[Caveat Emptor]

New 52 week HOD $1.20.

[RAND]

95 !!

[CVTaskForceTeam]

$1!!!!!!!! WEEEEEEEEEEEEEEEEE

[CVTaskForceTeam]

$1!!!!!!!! WEEEEEEEEEEEEEEEEE

[Awl416]

Mm caught hard

[buxmaker]

HLTY about to make new highs for the day.

[buxmaker]

HLTY about to make new highs for the day.

[CVTaskForceTeam]

in @.2125 LETTTTTTTTTTTS GOOOOOOO

[Caveat Emptor]

She's moving.

[davidsson10]

PreCheck Health to Exclusively Distribute Coronavirus (COVID 19) Test in Russia for a U.S Based Molecular Diagnostics Company

Wednesday, March 11, 2020 8:05 AM

Initial 7,500 coronavirus (COVID 19) test kits ordered
Enters $33 billion global infectious diseases markets

DENISON, TX / ACCESSWIRE / March 11, 2020 / PreCheck Health Services, Inc. (OTCPINK:HLTY), a provider of medical screening devices which provide data to assist physicians in preventing and treating chronic diseases, announced today it has entered into the $33 billion global infectious disease diagnostic testing sector with an exclusive agreement with a U.S. based molecular diagnostics company, to distribute its coronavirus 2019 (COVID 19) test which currently detects both strains of the COVID 19 virus and all of its products in Russia. PreCheck has ordered an initial 7,500 COVID 19 test kits and now will be registering the product for Russia.

Justin Anderson, Chief Executive Officer of PreCheck Health Services, commented, "We're excited to enter into this agreement which launches PreCheck into the global infectious disease diagnostic market. Although we are focused currently on the COVID 19 test to address the global crisis, we also look forward to leveraging the opportunity with all of our partner's products, to maximize shareholder value."

Further information is available in the Company's regulatory filing, which can be accessed at www.sec.gov.

About PreCheck Health Services, Inc.
PreCheck Health Services, Inc. provides a medical screening service, which makes early detection and monitoring of chronic diseases easy and cost-effective for patients and doctors. The Company distributes a non-invasive medical screening device which screens for biomarkers, which are precursors to chronic disease. The device assesses sudomotor function, cardiac autonomic function, and endothelial function and measures the ankle brachial indices. In addition, the device calculates a patented cardiometabolic risk score based on these assessments and measurements, body composition, vital signs, and fitness markers. Cardiometabolic risk refers to the chance of having or developing diabetes, heart disease, or stroke. This device is targeted at the rapidly growing $139 billion global preventive healthcare technologies and services market, according to Grand View Research. The Company has an experienced management team with several decades of combined experience in medical testing services and medical device sales. The technology has been developed to address the growing mandates from Medicare, Medicaid, and insurance companies regarding early detection and prevention of chronic diseases.

PreCheck Health Services' offering is based on the Company's PC8B, an FDA-cleared and patented medical screening device, which performs a range of screening tests generally covered and reimbursed by Medicare, Medicaid, and most insurance companies. The non-invasive diagnostic tests are performed simultaneously, collectively taking under 10 minutes to perform and screening patients for multiple risk factors underlying certain chronic ailments, such as insulin resistance, cardiovascular disease (including PAD), endothelia dysfunction, digestive problems, and fatigue. The PC8B's software helps the physician recommend a treatment plan for the patient.

[whytestocks]

News: $HLTY PreCheck Health Services, Inc. Announces Strategic Acquisitions

MIAMI, July 17, 2019 (GLOBE NEWSWIRE) -- PreCheck Health Services, Inc. (“PreCheck” or the “Company”) (OTC: HLTY), a provider of medical screening devices which provide data to assist physicians in preventing and treating chronic diseases, announced today that th...

In case you are interested PreCheck Health Services, Inc. Announces Strategic Acquisitions

[caly]

Can either of you provide the link to the FDA approval listing? I'm unable to find it under the PC8B name.

Thanks.

https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/default.htm

[jedijazz]

PreCheck Health Services, Inc. $HLTY is a Florida corporation that has entered into an exclusive distribution agreement for the “PC8B” medical device for sale coast to coast in the United States.

Read more: https://finance.yahoo.com/news/precheck-health-services-inc-signs-130000931.html

[jedijazz]

Twenty Three positive peer reviews Thank you for posting. $HLTY

[ProfitScout]

That's an impressive page of peer reviews for the PreCheck Health Services PC8B medical device as listed on the company website. This page certainly reflects the growing awareness and acknowledgment of the medical community for this advanced new screening system.

Here is a paste of the listings from the HLTY website:

Peer Reviews of the PC8B utilized technologies.

1. American Diabetes Association and American Academy of Neurology. Consensus statement: report and recommendations of the San Antonio Conferenceon Diabetic Neuropathy. Diabetes Care 1988; 11: 592–597.

2. Tesfaye S, Boulton AJ, Dyck PJ, et al.Diabetic neuropathies: update on de?nitions,diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33: 2285–2293.

3. Ziegler D, Gries FA, Muhlen H, et al.Prevalence and clinical correlates of cardiovascularautonomic and peripheral diabetic neuropathy in patients attending diabetes centers. Diabetes Metab 1993; 19: 143–151.

4. Valensi P, Paries J, Attali JR; French Group for Research and Study of Diabetic Neuropathy. Cardiac autonomic neuropathy in diabetic patients:in?uence of diabetes duration, obesity, and microangiopathic complications– the French multicenter study.Metabolism 2003; 52: 815–820.

5. Low PA, Benrud-Larson LM, Sletten DM, et al. Autonomic symptoms and diabetic neuropathy: a population-based study.Diabetes Care 2004; 27: 2942–2947.

6. Pop-Busui R, Low PA, Waberski BH,et al. Effects of prior intensive insulintherapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications.Trial/Epidemiology of Diabetes.Interventions and Complications study (DCCT/EDIC). Circulation 2009; 119: 2886–2893.

7. Ewing DJ, Martyn CN, Young RJ,Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985; 8: 491–498.

8. Kempler P, Tesfaye S, Chaturvedi N, et al. Blood pressure response to standing in the diagnosis of autonomic neuropathy: the EURODIAB IDDM Complications Study. Arch Physiol Biochem 2001; 109: 215–222.

9. Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003; 26:1895–1901.

10. Wheeler SG, Ahroni JH, Boyko EJ. Prospective study of autonomic neuropathy as a predictor of mortality inpatients with diabetes. Diabetes Res Clin Pract 2002; 58: 131–138.

11. Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH. Cardiac autonomic neuropathy predicts cardiovascularmorbidity and mortality intype 1 diabetic patients with diabetic nephropathy. Diabetes Care 2006; 29: 334–339.

12. Wackers FJ, Young LH, Inzucchi SE, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care2004; 27: 1954–1961.

13. Valensi P, Sachs RN, Harfouche B, et al.Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. DiabetesCare 2001; 24: 339–343.

14. Ryden L, Standl E, Bartnik M, et al.Guidelines on diabetes, pre-diabetes,and cardiovascular diseases: executivesummary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC)and of the European Association for theStudy of Diabetes (EASD). Eur Heart J.2007; 28: 88–136.

15. Millasseau SC et al. Determination of age-related increases in large artery sti?ness by digital pulse contour analysis. Clinical Science (2002) 103, 371±377.

16. Takazawa, K et al. Assessment of Vasoactive Agents and Vascular Aging by the Second Derivative of Photoplethysmogram Waveform. Hypertension: Volume 32(2) August 1998pp 365-370

17. Bagherzadeh et al. Association of cardiac autonomic neuropathy with endothelial dysfunction in type 2 diabetes mellitus patients. Journal of Diabetes & Metabolic Disorders 2013, 12:55

18. Dimitropoulos G, Tahrani AA, Stevens MJ. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes 2014 February 15; 5(1): 17-39.

19. Spallone V.et al.. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management .Diabetes Metab Res Rev 2011; 27: 639–653.

20. Jae-Seung Yun et al. Cardiovascular Autonomic Dysfunction Predicts Severe Hypoglycemia in Patients With Type 2 Diabetes: A 10-Year Follow-up Study. Diabetes Care Volume 37, January 2014

21. ACCORD study publication. NIH news

22. Ben M.W. Illigens, Christopher H. Gibbons. Sweat testing to evaluate autonomic function Clin Auton. Res. 2009 April; 19(2): 79–87.

23. Aboyans V. et al. Measurement and Interpretation of the Ankle-Brachial Index: A Scientific Statement from the American Heart Association. Circulation, November 2012.

[jedijazz]

HLTY Peer Reviews of the PC8B utilized technologies. https://precheckhealth.com/peer-reviews-of-the-pc8b-utilized-technologies/

[ProfitScout]

The PC8B Medical Device from PreCheck Health Services is a state-of-the-art system for detecting a range of medical problems early on so that healthcare professionals can have the best opportunities to deal with them and prevent progression. This is the way to protect every patient from needless long-term treatment regimes that can have undesired side effects. Catching problems early can also save huge amounts of costs later on.

PreCheck Health Services Inc. is a Florida corporation focused on the exclusive U.S. distribution of a medical diagnostic device, the PC8B. The PC8B medical device is a powerful screening tool in managing patient’s health. Scientifically validated and FDA cleared, this medical device performs a range of tests that are covered and reimbursed by most insurance companies. The manufacturer holds multiple patents on the device and continues to evolve the technology. This system is non-invasive and combined with a fast ABI (Ankle Brachial Index) test, takes less than 8 minutes to complete an assessment. The device provides physicians with a comprehensive overview of a patient’s health at-a-glance. The screening system provides patient insights covering 8 key risk factors. Depending on the risk score for each factor, the physician will be able to determine the best course of action to resolve the patient’s condition, as well as motivate the patient to immediate action.

The Company’s website is: http://www.precheckhealthservices.com

[jedijazz]

To learn more about how the PreCheck Health Services “PC8B” medical device works, please view this excerpt from a training video for the device

.

https://globenewswire.com/news-release/2019/01/22/1703356/0/en/PreCheck-Health-Services-Inc-signs-exclusive-distribution-agreement-on-the-company-s-new-medical-device.html HLTY

[ProfitScout]

That's the most important factor here. Preventative medical screening as provided by PreCheck Health Services can save tremendous amounts of money for the individual, the healthcare providers, the insurance industry and also the government by catching problems early when they are much easier and cheaper to address. Everyone will benefit from the increasingly widespread use of systems like the PC8B device.

It's a win-win situation here. I am looking forward to more HLTY updates soon.

[jedijazz]

$HLTY “By entering into this exclusive agreement we now can provide doctors with one of the best screening devices in the United States. Under the Affordable Care Act, physicians are being asked to provide more preventive care than previously required. Insurance companies as well as Medicare and Medicaid have learned that preventive care will reduce their cost of insuring patients. If chronic diseases are detected early, not only are we saving patients from the onset of chronic disease, the insurer and patient will save tens of thousands of dollars for care over the life of the patient,” stated Lawrence Biggs, the CEO of PreCheck Health Services, Inc.

To learn more about how the PreCheck Health Services “PC8B” medical device works, please view this excerpt from a training video for the device

.

https://globenewswire.com/news-release/2019/01/22/1703356/0/en/PreCheck-Health-Services-Inc-signs-exclusive-distribution-agreement-on-the-company-s-new-medical-device.html

[ProfitScout]

The PC8B medical screening device is a state-of-the-art technology that will find applications in a wide range of diagnostic roles today. PreCheck Health Service is in a very advantageous position with its current holding of the distribution rights for the PC8B.

From the January 22nd HLTY news:

The PC8B medical device is a powerful screening tool to provide physicians with data to help manage patient’s health. Scientifically validated and FDA cleared, this medical device performs a range of tests that are covered and reimbursed by Medicare and Medicaid as well as most insurance companies. The manufacturer holds multiple patents on the device and continues to evolve the technology.

This system is non-invasive and combined with a fast ABI (Ankle Brachial Index) test, takes less than 8 minutes to complete an assessment. The device provides physicians with a one-page comprehensive overview of a patient’s health at-a-glance. The screening system provides patient insights covering key risk factors. Depending on the risk score for each factor, the physician will be able to determine the best course of action to resolve the patient’s condition, as well as motivate the patient to immediate action. The capabilities of the PC8B gives physicians the opportunity for early diagnosis and the ability to prevent many chronic conditions and diseases.

[jedijazz]

$HLTY holds the exclusive U.S. distribution rights of the medical screening device, the PC8B. PreCheck Training Video

[ProfitScout]

Preventative medical screening is one of the most important and growing areas in the field of medicine today. Catching dangerous conditions and disease issues early is the best way to ensure a longer, healthier life and also avoid the high costs of treatments and increased insurance rates. PreCheck's PC8B is an ideal technology for this vital role.

PreCheck Health Services Inc. is a Florida corporation focused on the exclusive U.S. distribution of a medical diagnostic device, the PC8B. The PC8B medical device is a powerful screening tool in managing patient’s health. Scientifically validated and FDA cleared, this medical device performs a range of tests that are covered and reimbursed by most insurance companies. The manufacturer holds multiple patents on the device and continues to evolve the technology. This system is non-invasive and combined with a fast ABI (Ankle Brachial Index) test, takes less than 8 minutes to complete an assessment. The system screens patients and provides physicians with insights to the patient’s health. By screening for certain biomarkers, the device provides indication of risk factors for certain chronic disease. Depending on the risk score for each factor, the physician will be able to determine the best course of action to resolve the patient’s condition, as well as motivate the patient to immediate action.

Connect with us: The Company’s website is: http://www.precheckhealthservices.com

[jedijazz]

$HLTY PreCheck Health Services Inc. is a publicly traded Florida corporation with headquarters in Dennison, TX. The company holds the exclusive U.S. distribution rights of the medical screening device, the PC8B. PreCheck Training Video https://youtu.be/4TEOwjMBTEE

[jedijazz]

Link to the latest news on HLTY: http://finance.yahoo.com/q/h?s=HIPC+Headlines

[ProfitScout]

CEO Lawrence Biggs explains the benefits of the PreCheck PC8B screening system very well in the following interview he gave recently:

Lawrence Biggs, CEO of PreCheck Health Services, Inc., is Featured in an Exclusive New Audio Interview with SmallCapVoice.com
 
The interview featuring HLTY’s current news and industry trends can be heard at https://smallcapvoice.com/11-9-18-smallcapvoice-interview-with-precheck-health-services-inc-hlty/.

[jedijazz]

The PC8B medical device is a powerful screening tool to provide physicians with data to help manage patient’s health. Scientifically validated and FDA cleared, this medical device performs a range of tests that are covered and reimbursed by Medicare and Medicaid as well as most insurance companies. The manufacturer holds multiple patents on the device and continues to evolve the technology. HLTY

[ProfitScout]

Yes, I have been reviewing all the materials available on HLTY too including the company website here: http://www.precheckhealthservices.com.

This is a very well managed company with outstanding medical technology that is fully validated, and FDA approved. I expect 2019 to be a very good year for HLTY shareholders.

About PreCheck Health Services, Inc.

PreCheck Health Services Inc. is a Florida corporation focused on the exclusive U.S. distribution of a medical diagnostic device, the PC8B. The PC8B medical device is a powerful screening tool in managing patient’s health. Scientifically validated and FDA cleared, this medical device performs a range of tests that are covered and reimbursed by most insurance companies. The manufacturer holds multiple patents on the device and continues to evolve the technology. This system is non-invasive and combined with a fast ABI (Ankle Brachial Index) test, takes less than 8 minutes to complete an assessment. The device provides physicians with a comprehensive overview of a patient’s health at-a-glance. The screening system provides patient insights covering 8 key risk factors. Depending on the risk score for each factor, the physician will be able to determine the best course of action to resolve the patient’s condition, as well as motivate the patient to immediate action.

[jedijazz]

Very nice news! HLTY PreCheck Health Services, Inc. signs exclusive distribution agreement on the company’s new medical device

https://globenewswire.com/news-release/2019/01/22/1703356/0/en/PreCheck-Health-Services-Inc-signs-exclusive-distribution-agreement-on-the-company-s-new-medical-device.html

[ProfitScout]

Note that there is a filing out today from HLTY with a new business summary attached. It's very good to see detailed reports like this which reflect management providing good transparency for investors.

Link:
https://ih.advfn.com/stock-market/USOTC/precheck-health-services-inc-HLTY/stock-news/79203743/current-report-filing-8-k

Item 7.01 Regulation FD Disclosure

In connection with an investor presentation, on February 6, 2019, the Company prepared a business summary describing its present and proposed business activities. A copy of the business summary is included as Exhibit 99.1 to this Form 8-K.

In accordance with General Instruction B.2 of Form 8-K, the information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth by specific reference in such a filing.

[ProfitScout]

There is a lot more very informative commentary from CEO Lawrence Biggs available here. Well worth the time to review for everyone interested in HLTY:

Lawrence Biggs, CEO of PreCheck Health Services, Inc., is Featured in an Exclusive New Audio Interview with SmallCapVoice.com

Links:
https://globenewswire.com/news-release/2018/11/15/1652183/0/en/Lawrence-Biggs-CEO-of-PreCheck-Health-Services-Inc-is-Featured-in-an-Exclusive-New-Audio-Interview-with-SmallCapVoice-com.html

The interview featuring HLTY’s current news and industry trends can be heard at https://smallcapvoice.com/11-9-18-smallcapvoice-interview-with-precheck-health-services-inc-hlty/.

CEO Lawrence Biggs called in to SmallCapVoice.com to go over his Company’s new business model, markets they operate in, management team and much more.

[ProfitScout]

The comments from CEO Lawrence Biggs highlight the sweeping value of the new distribution agreement for PreCheck's advanced medical screening technology in today's cost-conscious healthcare marketplace:

“By entering into this exclusive agreement we now can provide doctors with one of the best screening devices in the United States. Under the Affordable Care Act, physicians are being asked to provide more preventive care than previously required. Insurance companies as well as Medicare and Medicaid have learned that preventive care will reduce their cost of insuring patients. If chronic diseases are detected early, not only are we saving patients from the onset of chronic disease, the insurer and patient will save tens of thousands of dollars for care over the life of the patient,” stated Lawrence Biggs, the CEO of PreCheck Health Services, Inc.

[jedijazz]

HLTY YouTube Video: To learn more about how the PreCheck Health Services “PC8B” medical device works: https://www.youtube.com/watch?v=4TEOwjMBTEE

[jedijazz]

$HLTY News: PreCheck Health Services, Inc. signs exclusive distribution agreement on the company’s new medical device..https://finance.yahoo.com/news/precheck-health-services-inc-signs-130000931.html To learn more about how the PreCheck Health Services “PC8B” medical device works:

[ProfitScout]

The PreCheck training video that is available on youTube is very clear and does a nice job of explaining all the benefits of the company's new PC8B medical screening device. It's less than 5 minutes long and certainly worth the time to watch so you can understand why this type of screening is so important and valuable. Very good info everyone involved with HLTY.

Link:

[ProfitScout]

We should be hearing more about the new distribution agreement for PreCheck Health's advanced PC8B medical device soon. This is a very promising new technology that should be the company's focus of marketing efforts going forward.
----------------------------------------------------------------
The PC8B medical device is a powerful screening tool to provide physicians with data to help manage patient’s health. Scientifically validated and FDA cleared, this medical device performs a range of tests that are covered and reimbursed by Medicare and Medicaid as well as most insurance companies. The manufacturer holds multiple patents on the device and continues to evolve the technology.

This system is non-invasive and combined with a fast ABI (Ankle Brachial Index) test, takes less than 8 minutes to complete an assessment. The device provides physicians with a one-page comprehensive overview of a patient’s health at-a-glance. The screening system provides patient insights covering key risk factors. Depending on the risk score for each factor, the physician will be able to determine the best course of action to resolve the patient’s condition, as well as motivate the patient to immediate action. The capabilities of the PC8B gives physicians the opportunity for early diagnosis and the ability to prevent many chronic conditions and diseases.

To learn more about how the PreCheck Health Services “PC8B” medical device works, please view this excerpt from a training video for the device

.

[ProfitScout]

I am looking forward to hearing more about progress with PreCheck's new commercial distribution agreement for the company's advanced PC8B medical device. There is so much potential for this technology to help a wide range of patients. I am expecting a lot more HLTY news to come on this from in 2019.

To learn more about how the PreCheck Health Services “PC8B” medical device works, please view this excerpt from a training video for the device

.

[ProfitScout]

Today is the MedTech Monday Conference for PreCheck management's presentation of the PC8B technology.

From the latest HLTY news:

“We are excited to be presenting at this conference with many of the new innovative medical device companies in the market today. This gives us the opportunity to not only create sales channels for our device but to present to investment firms in the space which may be interested in funding our rollout of the new PC8B medical device.” stated Lawrence Biggs, the CEO of PreCheck Health Services, Inc.

To learn more about how the PreCheck Health Services “PC8B” medical device works, please view this excerpt from a training video for the device

.

[ProfitScout]

Coming right up on Monday of next week. A lot more eyes and ears will be getting the HLTY growth story. No time wasted here.

[StockHighAlert-]

$HLTY PreCheck Health Services, Inc. to present at the 5th annual MedTech Monday conference https://finance.yahoo.com/news/precheck-health-services-inc-present-132845589.html

[ProfitScout]

Very good to see this high profile presentation for HLTY coming right up next week. This will open a lot of new eyes to PreCheck's capabilities and the new PC8B medical device which offers so much potential to help a wide range of patients.

From today's abbouncement:

“We are excited to be presenting at this conference with many of the new innovative medical device companies in the market today. This gives us the opportunity to not only create sales channels for our device but to present to investment firms in the space which may be interested in funding our rollout of the new PC8B medical device.” stated Lawrence Biggs, the CEO of PreCheck Health Services, Inc.

[jedijazz]

$HLTY ~ PreCheck Health Services, Inc. to present at the 5th annual MedTech Monday conference

MIAMI, Jan. 24, 2019 (GLOBE NEWSWIRE) -- PreCheck Health Services, Inc. (HLTY), will be presenting at MedTech Monday in Costa Mesa California at the Avenue of the Arts next week on Monday the 28th of January.

This is the 5th annual MedTech Monday conference that provides Orange County with the latest medical device innovations, investment insights, biotech advancements, startups and discussions with industry leaders on the direction of the industry here in 2019 and beyond.

“We are excited to be presenting at this conference with many of the new innovative medical device companies in the market today. This gives us the opportunity to not only create sales channels for our device but to present to investment firms in the space which may be interested in funding our rollout of the new PC8B medical device.” stated Lawrence Biggs, the CEO of PreCheck Health Services, Inc.

To learn more about how the PreCheck Health Services “PC8B” medical device works, please view this excerpt from a training video for the device

.

About PreCheck Health Services, Inc.

PreCheck Health Services Inc. is a Florida corporation focused on the exclusive U.S. distribution of a medical diagnostic device, the PC8B. The PC8B medical device is a powerful screening tool in managing patient’s health. Scientifically validated and FDA cleared, this medical device performs a range of tests that are covered and reimbursed by most insurance companies. The manufacturer holds multiple patents on the device and continues to evolve the technology. This system is non-invasive and combined with a fast ABI (Ankle Brachial Index) test, takes less than 8 minutes to complete an assessment. The system screens patients and provides physicians with insights to the patient’s health. By screening for certain biomarkers, the device provides indication of risk factors for certain chronic disease. Depending on the risk score for each factor, the physician will be able to determine the best course of action to resolve the patient’s condition, as well as motivate the patient to immediate action.

Connect with us: The Company’s website is: www.precheckhealthservices.com

Disclaimer for Forward-Looking Information:

This news release may contain forward-looking statements which include, but are not limited to, comments that involve future events and conditions, which are subject to various risks and uncertainties. Except for statements of historical facts, comments that address resource potential, upcoming work programs, geological interpretations, receipt and security of mineral property titles, availability of funds, and others are forward-looking. Forward-looking statements are not guarantees of future performance and actual results may vary materially from those statements. General business conditions are factors that could cause actual results to vary materially from forward-looking statements.

Investor inquiries contact:
Stuart Smith
SmallCapVoice.Com, Inc.

email: [e-mail]

P. 512-267-2430

[ProfitScout]

Nice upticks here with a pop up to $1.20 this morning. HLTY should have an easy uptrend as the company beings out news of its plans and progress for 2019. This is one to follow now.

About PreCheck Health Services, Inc.

PreCheck Health Services Inc. is a Florida corporation focused on the exclusive U.S. distribution of a medical diagnostic device, the PC8B. The PC8B medical device is a powerful screening tool in managing patient’s health. Scientifically validated and FDA cleared, this medical device performs a range of tests that are covered and reimbursed by most insurance companies. The manufacturer holds multiple patents on the device and continues to evolve the technology. This system is non-invasive and combined with a fast ABI (Ankle Brachial Index) test, takes less than 8 minutes to complete an assessment. The device provides physicians with a comprehensive overview of a patient’s health at-a-glance. The screening system provides patient insights covering 8 key risk factors. Depending on the risk score for each factor, the physician will be able to determine the best course of action to resolve the patient’s condition, as well as motivate the patient to immediate action.

[jedijazz]

$HLTY Nature's Best Brands Inc (HLTY) 1.0400 +0.0300 (+2.97%) 09:51 ET [OTC US] TECHNICAL ANALYSIS for Tue, Jan 22nd, 2019 https://www.barchart.com/stocks/quotes/HLTY/technical-analysis

[StockHighAlert-]

Great News! $HLTY PreCheck Health Services, Inc. signs exclusive distribution agreement on the company’s new medical device https://finance.yahoo.com/news/precheck-health-services-inc-signs-130000931.html

[ProfitScout]

Excellent to see in the HLTY news today that the company's advanced PC8B medical device will now be available to many more patients who can greatly benefit from it all across the country.

From today's news:

The PC8B medical device is a powerful screening tool to provide physicians with data to help manage patient’s health. Scientifically validated and FDA cleared, this medical device performs a range of tests that are covered and reimbursed by Medicare and Medicaid as well as most insurance companies. The manufacturer holds multiple patents on the device and continues to evolve the technology.

This system is non-invasive and combined with a fast ABI (Ankle Brachial Index) test, takes less than 8 minutes to complete an assessment. The device provides physicians with a one-page comprehensive overview of a patient’s health at-a-glance. The screening system provides patient insights covering key risk factors. Depending on the risk score for each factor, the physician will be able to determine the best course of action to resolve the patient’s condition, as well as motivate the patient to immediate action. The capabilities of the PC8B gives physicians the opportunity for early diagnosis and the ability to prevent many chronic conditions and diseases.

[jedijazz]

“By entering into this exclusive agreement we now can provide doctors with one of the best screening devices in the United States. Under the Affordable Care Act, physicians are being asked to provide more preventive care than previously required. Insurance companies as well as Medicare and Medicaid have learned that preventive care will reduce their cost of insuring patients. If chronic diseases are detected early, not only are we saving patients from the onset of chronic disease, the insurer and patient will save tens of thousands of dollars for care over the life of the patient,” stated Lawrence Biggs, the CEO of PreCheck Health Services, Inc.

To learn more about how the PreCheck Health Services “PC8B” medical device works, please view this excerpt from a training video for the device

$PLTY